FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025: SNAP BENEFITS LINKED TO SLOWER COGNITIVE DECLINE, 10-YEAR STUDY FINDS
Key Takeaways Participating in the Supplemental Nutrition Assistance Program (SNAP) may help…
Sharecare to collaborate with Centers for Medicare & Medicaid Services to improve care quality, accelerate progress in healthcare
Company doubles down on its commitment to transform personal health journey of…
Spineway : H1 2025 results – Continued improvement in results and financial position
Press release Ecully, July 30, 2025 – 7 p.m. SPINEWAY H1 2025…
Egg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of All Claims in Rampart IC’s Radiation Shield Patent Following a Reexamination Challenge
ST. PAUL, Minn., July 30, 2025 /PRNewswire/ -- In a significant development in…
Emerald Clinical Trials Confirms CEO Transition and Continuity Plan
SINGAPORE, July 30, 2025 /PRNewswire/ -- Emerald Clinical Trials, a leading global…
Rakovina Therapeutics Announces Stock Option Grants
July 29, 2025 17:00 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British…
Information on the total number of voting rights and shares
REGULATED INFORMATION Information on the total number of voting rights and shares…
FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025: ALZHEIMER’S ASSOCIATION RELEASES ITS FIRST CLINICAL PRACTICE GUIDELINE FOR BLOOD-BASED BIOMARKER TESTS
Key Takeaways At AAIC 2025, the Alzheimer's Association released the first in…
Alamar Biosciences and the German Center for Neurodegenerative Diseases (DZNE) partner for Landmark Proteomic Profiling study in the Rhineland Study Cohort
NULISAseq™ CNS Disease Panel 120 and Inflammation Panel 250 to Power Biomarker…
FDA Approves Apellis EMPAVELI (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
Proven efficacy across all three key markers of disease—68% reduction in proteinuria,…